AI MARKET SCANNING

Olema Pharmaceuticals Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +2.93%
MAX GAP RECORD +15.16%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $OLMA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 10, 2026 Earnings Release 2026-08-10 (BEFORE OPEN)
-1.08%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
-2.15%
Mar 16, 2026 Earnings Release 2026-03-16 (BEFORE OPEN)
+2.65%
Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN)
+0.00%
Aug 11, 2025 Earnings Release 2025-08-11 (AFTER CLOSE)
+7.88%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
+6.20%
Mar 18, 2025 Earnings Release 2025-03-18 (AFTER CLOSE)
+10.39%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
+3.03%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.2%
Bullish Gaps (9)
Bearish Gaps (4)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $OLMA

EXECUTIONS2 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 3904m +9.09%
••••-••-•• 🔒 LOCKED ••• x• $•••.•• → $•••.•• ••m +••.••%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗